Paul Drew
Concepts (360)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ethanol | 14 | 2024 | 322 | 5.790 |
Why?
| Microglia | 28 | 2024 | 137 | 5.780 |
Why?
| Astrocytes | 10 | 2021 | 142 | 2.670 |
Why?
| Cerebellum | 8 | 2024 | 142 | 2.340 |
Why?
| Alcoholism | 4 | 2023 | 249 | 2.310 |
Why?
| Hippocampus | 9 | 2022 | 242 | 2.090 |
Why?
| Multiple Sclerosis | 10 | 2021 | 72 | 1.900 |
Why?
| Central Nervous System | 5 | 2020 | 85 | 1.850 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 10 | 2014 | 21 | 1.660 |
Why?
| Animals | 61 | 2024 | 14385 | 1.500 |
Why?
| Mice, Inbred C57BL | 24 | 2023 | 1999 | 1.440 |
Why?
| Mice | 36 | 2024 | 6413 | 1.410 |
Why?
| PPAR gamma | 6 | 2017 | 79 | 1.370 |
Why?
| Prostaglandin D2 | 8 | 2011 | 27 | 1.250 |
Why?
| Animals, Newborn | 10 | 2021 | 396 | 1.250 |
Why?
| Cytokines | 19 | 2021 | 676 | 1.210 |
Why?
| Receptors, Cytoplasmic and Nuclear | 9 | 2009 | 85 | 1.140 |
Why?
| Thiazolidinediones | 5 | 2017 | 95 | 1.050 |
Why?
| Nitric Oxide | 14 | 2012 | 298 | 1.020 |
Why?
| Neurogenesis | 2 | 2021 | 30 | 1.010 |
Why?
| Disease Models, Animal | 10 | 2024 | 1639 | 0.980 |
Why?
| Transcription Factors | 13 | 2004 | 622 | 0.980 |
Why?
| DNA-Binding Proteins | 7 | 2009 | 462 | 0.970 |
Why?
| PPAR alpha | 5 | 2009 | 64 | 0.950 |
Why?
| Neuroimmunomodulation | 2 | 2014 | 14 | 0.920 |
Why?
| Immunity | 2 | 2013 | 36 | 0.920 |
Why?
| Brain | 8 | 2013 | 1387 | 0.900 |
Why?
| Central Nervous System Depressants | 2 | 2013 | 78 | 0.900 |
Why?
| Retinoid X Receptors | 5 | 2006 | 16 | 0.880 |
Why?
| Transcriptome | 2 | 2023 | 346 | 0.850 |
Why?
| Cells, Cultured | 21 | 2017 | 1737 | 0.830 |
Why?
| Gene Expression Regulation | 13 | 2017 | 1062 | 0.820 |
Why?
| RNA, Messenger | 15 | 2021 | 1202 | 0.810 |
Why?
| Pregnancy | 10 | 2024 | 2620 | 0.800 |
Why?
| Interleukin-12 | 3 | 2007 | 37 | 0.800 |
Why?
| Zinc Fingers | 5 | 1997 | 21 | 0.760 |
Why?
| Neurons | 8 | 2017 | 486 | 0.750 |
Why?
| Cerebral Cortex | 9 | 2021 | 234 | 0.710 |
Why?
| Immunity, Cellular | 3 | 2015 | 80 | 0.700 |
Why?
| Tretinoin | 5 | 2005 | 56 | 0.670 |
Why?
| Neuroglia | 4 | 2007 | 52 | 0.640 |
Why?
| Cell Survival | 11 | 2012 | 657 | 0.640 |
Why?
| T-Lymphocytes, Helper-Inducer | 3 | 2017 | 46 | 0.630 |
Why?
| Anti-Inflammatory Agents | 3 | 2020 | 175 | 0.620 |
Why?
| Encephalomyelitis | 2 | 2017 | 6 | 0.620 |
Why?
| Aging | 2 | 2013 | 784 | 0.610 |
Why?
| Alcoholic Neuropathy | 1 | 2016 | 2 | 0.580 |
Why?
| Enzyme-Linked Immunosorbent Assay | 11 | 2012 | 314 | 0.570 |
Why?
| Inflammation | 7 | 2012 | 674 | 0.560 |
Why?
| DNA, Complementary | 8 | 2013 | 145 | 0.560 |
Why?
| Lipopolysaccharides | 11 | 2012 | 199 | 0.540 |
Why?
| Autoimmunity | 3 | 2011 | 38 | 0.530 |
Why?
| Tumor Necrosis Factor-alpha | 9 | 2013 | 434 | 0.500 |
Why?
| RNA | 4 | 2023 | 202 | 0.500 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2012 | 142 | 0.490 |
Why?
| Encephalitis | 2 | 2006 | 48 | 0.460 |
Why?
| Drug Interactions | 7 | 2012 | 206 | 0.460 |
Why?
| Analysis of Variance | 7 | 2012 | 635 | 0.450 |
Why?
| Naphthoquinones | 1 | 2012 | 14 | 0.440 |
Why?
| Mitoxantrone | 1 | 2012 | 11 | 0.440 |
Why?
| Dose-Response Relationship, Drug | 11 | 2014 | 1476 | 0.440 |
Why?
| 5-Aminolevulinate Synthetase | 5 | 1990 | 5 | 0.420 |
Why?
| Nerve Tissue Proteins | 3 | 1997 | 199 | 0.400 |
Why?
| Oligodendroglia | 2 | 2021 | 34 | 0.400 |
Why?
| Female | 15 | 2024 | 28441 | 0.390 |
Why?
| NF-kappa B | 7 | 2006 | 335 | 0.380 |
Why?
| Interleukin-17 | 2 | 2011 | 38 | 0.370 |
Why?
| Nitric Oxide Synthase | 5 | 2001 | 102 | 0.370 |
Why?
| Toll-Like Receptor 4 | 2 | 2023 | 51 | 0.370 |
Why?
| Peroxisome Proliferator-Activated Receptors | 2 | 2006 | 16 | 0.360 |
Why?
| Fenofibrate | 3 | 2009 | 16 | 0.350 |
Why?
| Chemokine CX3CL1 | 2 | 2021 | 9 | 0.340 |
Why?
| Immune Tolerance | 1 | 2009 | 104 | 0.340 |
Why?
| Toll-Like Receptors | 1 | 2009 | 25 | 0.340 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2021 | 151 | 0.330 |
Why?
| Inflammasomes | 2 | 2021 | 60 | 0.320 |
Why?
| Base Sequence | 13 | 1997 | 719 | 0.310 |
Why?
| Myeloid Differentiation Factor 88 | 2 | 2023 | 40 | 0.310 |
Why?
| Molecular Sequence Data | 13 | 1997 | 980 | 0.300 |
Why?
| Cognition Disorders | 2 | 2021 | 240 | 0.300 |
Why?
| Gene Expression | 5 | 2021 | 664 | 0.290 |
Why?
| Genes, MHC Class I | 4 | 1995 | 13 | 0.290 |
Why?
| Gliosis | 1 | 2006 | 6 | 0.290 |
Why?
| beta 2-Microglobulin | 3 | 1995 | 35 | 0.290 |
Why?
| Peroxisome Proliferators | 1 | 2005 | 8 | 0.270 |
Why?
| Prostaglandins A | 1 | 2005 | 2 | 0.270 |
Why?
| Chemokines | 4 | 2006 | 96 | 0.260 |
Why?
| Chemokine CCL2 | 3 | 2013 | 78 | 0.250 |
Why?
| Humans | 30 | 2024 | 54284 | 0.250 |
Why?
| Hemin | 3 | 1989 | 8 | 0.240 |
Why?
| Heme | 3 | 1989 | 24 | 0.240 |
Why?
| Sulfonamides | 3 | 2011 | 146 | 0.240 |
Why?
| Gonadal Steroid Hormones | 1 | 2003 | 42 | 0.230 |
Why?
| Nitric Oxide Synthase Type II | 5 | 2008 | 83 | 0.230 |
Why?
| Apoptosis | 2 | 2021 | 1300 | 0.230 |
Why?
| Myelin-Oligodendrocyte Glycoprotein | 3 | 2014 | 7 | 0.230 |
Why?
| Cytokine-Induced Killer Cells | 1 | 2023 | 2 | 0.230 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 43 | 0.230 |
Why?
| Central Nervous System Diseases | 1 | 2003 | 30 | 0.220 |
Why?
| Allylisopropylacetamide | 4 | 1990 | 4 | 0.220 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 206 | 0.220 |
Why?
| Chromosome Mapping | 3 | 1997 | 175 | 0.220 |
Why?
| Male | 7 | 2024 | 27334 | 0.220 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 208 | 0.220 |
Why?
| Interferon-gamma | 5 | 2005 | 195 | 0.210 |
Why?
| Myelin Sheath | 1 | 2021 | 28 | 0.200 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2014 | 180 | 0.200 |
Why?
| T-Lymphocytes | 3 | 2007 | 373 | 0.200 |
Why?
| Interneurons | 1 | 2021 | 37 | 0.200 |
Why?
| Estriol | 1 | 2000 | 5 | 0.200 |
Why?
| Dehydroepiandrosterone | 1 | 2000 | 16 | 0.190 |
Why?
| Amino Acid Sequence | 6 | 1997 | 767 | 0.190 |
Why?
| Progesterone | 1 | 2000 | 69 | 0.190 |
Why?
| Interleukins | 3 | 2011 | 39 | 0.190 |
Why?
| Polysaccharides | 2 | 2012 | 57 | 0.180 |
Why?
| Chronic Disease | 1 | 2023 | 614 | 0.180 |
Why?
| Hydrocortisone | 1 | 2000 | 124 | 0.180 |
Why?
| Cell Cycle | 1 | 2021 | 275 | 0.180 |
Why?
| Colorectal Neoplasms | 1 | 2023 | 236 | 0.180 |
Why?
| Acetamides | 2 | 1990 | 25 | 0.180 |
Why?
| Estradiol | 1 | 2000 | 219 | 0.170 |
Why?
| Histocompatibility Antigens Class I | 2 | 1995 | 52 | 0.170 |
Why?
| Hydroxycholesterols | 1 | 1998 | 9 | 0.170 |
Why?
| beta-Cyclodextrins | 1 | 1998 | 18 | 0.170 |
Why?
| Mice, Transgenic | 6 | 2017 | 656 | 0.160 |
Why?
| Thiazoles | 2 | 2011 | 61 | 0.160 |
Why?
| Orphan Nuclear Receptors | 2 | 2009 | 15 | 0.160 |
Why?
| Hydrocarbons, Fluorinated | 2 | 2009 | 8 | 0.160 |
Why?
| HTLV-I Infections | 1 | 1997 | 4 | 0.160 |
Why?
| Human T-lymphotropic virus 1 | 1 | 1997 | 3 | 0.160 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 1997 | 4 | 0.160 |
Why?
| Genes | 1 | 1997 | 38 | 0.160 |
Why?
| Receptors, CCR6 | 1 | 2017 | 4 | 0.160 |
Why?
| Gene Expression Regulation, Viral | 1 | 1997 | 50 | 0.160 |
Why?
| Tumor Cells, Cultured | 7 | 2001 | 477 | 0.150 |
Why?
| Peptide Fragments | 4 | 2014 | 242 | 0.150 |
Why?
| Conserved Sequence | 2 | 1997 | 57 | 0.150 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 1997 | 10 | 0.150 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 1997 | 30 | 0.150 |
Why?
| Liver | 3 | 1989 | 1225 | 0.150 |
Why?
| Protein Structure, Tertiary | 1 | 1997 | 289 | 0.150 |
Why?
| Receptors, HIV | 1 | 2016 | 2 | 0.150 |
Why?
| Receptors, Cytokine | 1 | 2016 | 13 | 0.150 |
Why?
| Antineoplastic Agents | 1 | 2005 | 1300 | 0.140 |
Why?
| Freund's Adjuvant | 2 | 2014 | 8 | 0.140 |
Why?
| Consensus Sequence | 1 | 1995 | 25 | 0.140 |
Why?
| Alzheimer Disease | 1 | 2000 | 367 | 0.140 |
Why?
| Sequence Homology, Amino Acid | 4 | 1997 | 180 | 0.140 |
Why?
| Transcription, Genetic | 3 | 2009 | 418 | 0.140 |
Why?
| Neuroprotective Agents | 1 | 2017 | 125 | 0.130 |
Why?
| Blotting, Western | 4 | 2009 | 683 | 0.130 |
Why?
| Acromegaly | 1 | 2015 | 8 | 0.130 |
Why?
| Behavior, Animal | 1 | 2017 | 200 | 0.130 |
Why?
| Cellular Microenvironment | 1 | 2015 | 27 | 0.130 |
Why?
| Phosphoproteins | 1 | 1995 | 116 | 0.130 |
Why?
| Th17 Cells | 2 | 2014 | 26 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 1997 | 359 | 0.130 |
Why?
| Adipose Tissue, White | 1 | 2015 | 39 | 0.130 |
Why?
| Promoter Regions, Genetic | 6 | 2009 | 520 | 0.130 |
Why?
| Growth Hormone | 1 | 2015 | 78 | 0.130 |
Why?
| Rats | 5 | 2001 | 3415 | 0.130 |
Why?
| Ethylenes | 1 | 2014 | 6 | 0.130 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2016 | 173 | 0.120 |
Why?
| Repressor Proteins | 1 | 1995 | 165 | 0.120 |
Why?
| Interleukin-6 | 2 | 2013 | 315 | 0.120 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2013 | 37 | 0.120 |
Why?
| Interleukin-23 | 2 | 2012 | 10 | 0.120 |
Why?
| Genes, Regulator | 1 | 1993 | 5 | 0.120 |
Why?
| Spleen | 2 | 2012 | 186 | 0.120 |
Why?
| Immunohistochemistry | 3 | 2013 | 1089 | 0.120 |
Why?
| Dihydropyridines | 2 | 1990 | 10 | 0.110 |
Why?
| Testosterone | 3 | 1990 | 119 | 0.110 |
Why?
| Age Factors | 1 | 2016 | 1198 | 0.110 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 74 | 0.110 |
Why?
| Immunologic Factors | 2 | 2014 | 130 | 0.110 |
Why?
| Cloning, Molecular | 3 | 1997 | 198 | 0.110 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 232 | 0.110 |
Why?
| Chick Embryo | 5 | 1990 | 79 | 0.100 |
Why?
| Stilbenes | 1 | 2012 | 65 | 0.100 |
Why?
| Fetus | 2 | 2012 | 227 | 0.100 |
Why?
| Gemfibrozil | 2 | 2009 | 9 | 0.100 |
Why?
| Dendritic Cells | 1 | 2012 | 142 | 0.100 |
Why?
| Bone Marrow Cells | 1 | 2012 | 233 | 0.100 |
Why?
| Neurodegenerative Diseases | 1 | 2012 | 83 | 0.100 |
Why?
| Mental Disorders | 1 | 2016 | 451 | 0.100 |
Why?
| Severity of Illness Index | 2 | 2012 | 1084 | 0.100 |
Why?
| DNA | 4 | 2006 | 581 | 0.100 |
Why?
| Cell Count | 1 | 2011 | 181 | 0.100 |
Why?
| Receptors, Retinoic Acid | 2 | 2004 | 27 | 0.090 |
Why?
| Myelin Proteins | 1 | 2009 | 4 | 0.090 |
Why?
| Receptors, Interleukin | 1 | 2009 | 11 | 0.090 |
Why?
| Myelin-Associated Glycoprotein | 1 | 2009 | 9 | 0.090 |
Why?
| Isoenzymes | 1 | 1989 | 177 | 0.090 |
Why?
| Time Factors | 3 | 2012 | 3213 | 0.080 |
Why?
| Inflammation Mediators | 2 | 2007 | 128 | 0.080 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 1990 | 192 | 0.080 |
Why?
| Infant, Newborn | 1 | 2016 | 2907 | 0.080 |
Why?
| Brain Abscess | 1 | 2008 | 11 | 0.080 |
Why?
| Cell Line | 4 | 2017 | 1153 | 0.080 |
Why?
| Cell Differentiation | 1 | 2011 | 720 | 0.080 |
Why?
| Blotting, Northern | 3 | 1995 | 108 | 0.080 |
Why?
| Cell Proliferation | 2 | 2014 | 1096 | 0.080 |
Why?
| Tissue Distribution | 3 | 1995 | 178 | 0.080 |
Why?
| Immunosuppressive Agents | 1 | 2009 | 248 | 0.080 |
Why?
| Antigen-Presenting Cells | 1 | 2007 | 25 | 0.080 |
Why?
| Nitroprusside | 1 | 2006 | 12 | 0.070 |
Why?
| Irritable Bowel Syndrome | 1 | 2007 | 13 | 0.070 |
Why?
| Drug Synergism | 2 | 1998 | 171 | 0.070 |
Why?
| Adult | 3 | 2024 | 14207 | 0.070 |
Why?
| Leukocytes, Mononuclear | 1 | 2007 | 133 | 0.070 |
Why?
| Brain Neoplasms | 2 | 2001 | 284 | 0.070 |
Why?
| Tetrazolium Salts | 1 | 2005 | 17 | 0.070 |
Why?
| Interferon-alpha | 1 | 2005 | 50 | 0.070 |
Why?
| Transfection | 4 | 2009 | 399 | 0.070 |
Why?
| Inhibitory Concentration 50 | 1 | 2005 | 80 | 0.070 |
Why?
| Autoimmune Diseases | 1 | 2006 | 114 | 0.060 |
Why?
| Staphylococcal Infections | 1 | 2008 | 300 | 0.060 |
Why?
| Neuroblastoma | 2 | 1995 | 50 | 0.060 |
Why?
| Microbodies | 1 | 2004 | 3 | 0.060 |
Why?
| Staphylococcus aureus | 2 | 2008 | 361 | 0.060 |
Why?
| Adolescent | 1 | 2016 | 6897 | 0.060 |
Why?
| Macrophages | 2 | 2008 | 405 | 0.060 |
Why?
| Purkinje Cells | 1 | 2024 | 22 | 0.060 |
Why?
| Child | 1 | 2016 | 7341 | 0.060 |
Why?
| Ligands | 3 | 2011 | 230 | 0.060 |
Why?
| Immunotherapy, Adoptive | 1 | 2023 | 134 | 0.050 |
Why?
| Acetic Acid | 1 | 2001 | 12 | 0.050 |
Why?
| Neuroimaging | 1 | 2021 | 88 | 0.050 |
Why?
| Meningioma | 1 | 2001 | 43 | 0.050 |
Why?
| Dehydroepiandrosterone Sulfate | 1 | 2000 | 5 | 0.050 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 75 | 0.050 |
Why?
| Models, Biological | 1 | 2005 | 823 | 0.050 |
Why?
| Nitrites | 1 | 2000 | 39 | 0.050 |
Why?
| Protein Biosynthesis | 2 | 2017 | 273 | 0.050 |
Why?
| Glioma | 1 | 2001 | 78 | 0.050 |
Why?
| Clinical Trials as Topic | 1 | 2023 | 490 | 0.050 |
Why?
| Neuropsychological Tests | 1 | 2021 | 363 | 0.050 |
Why?
| Radiopharmaceuticals | 1 | 2001 | 238 | 0.050 |
Why?
| Cognition | 1 | 2021 | 348 | 0.040 |
Why?
| Cyclodextrins | 1 | 1998 | 17 | 0.040 |
Why?
| Spinal Cord | 2 | 2014 | 151 | 0.040 |
Why?
| Polymerase Chain Reaction | 2 | 1997 | 531 | 0.040 |
Why?
| DNA Fragmentation | 1 | 1998 | 67 | 0.040 |
Why?
| Paraparesis, Tropical Spastic | 1 | 1997 | 1 | 0.040 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 6 | 0.040 |
Why?
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1997 | 8 | 0.040 |
Why?
| Genetic Code | 1 | 1997 | 4 | 0.040 |
Why?
| Drosophila melanogaster | 1 | 1997 | 24 | 0.040 |
Why?
| Mammals | 1 | 1997 | 57 | 0.040 |
Why?
| Kruppel-Like Transcription Factors | 1 | 1997 | 40 | 0.040 |
Why?
| RNA Stability | 1 | 2017 | 28 | 0.040 |
Why?
| Autoimmune Diseases of the Nervous System | 1 | 2017 | 9 | 0.040 |
Why?
| Species Specificity | 1 | 1997 | 205 | 0.040 |
Why?
| 3' Untranslated Regions | 1 | 2017 | 57 | 0.040 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 1997 | 113 | 0.040 |
Why?
| RNA Interference | 1 | 2017 | 195 | 0.040 |
Why?
| Rats, Sprague-Dawley | 1 | 2000 | 1663 | 0.040 |
Why?
| Prospective Studies | 1 | 2023 | 2604 | 0.040 |
Why?
| Rats, Wistar | 1 | 2017 | 237 | 0.040 |
Why?
| Evolution, Molecular | 1 | 1997 | 103 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 1997 | 218 | 0.040 |
Why?
| Interferon Regulatory Factor-2 | 1 | 1995 | 3 | 0.040 |
Why?
| Cell Movement | 1 | 2017 | 271 | 0.030 |
Why?
| Interferon Regulatory Factor-1 | 1 | 1995 | 14 | 0.030 |
Why?
| Stimulation, Chemical | 1 | 1995 | 33 | 0.030 |
Why?
| Pregnancy Complications | 1 | 2000 | 384 | 0.030 |
Why?
| Nuclear Proteins | 1 | 1997 | 252 | 0.030 |
Why?
| Measles virus | 1 | 1995 | 9 | 0.030 |
Why?
| Transcription Factor TFIIIA | 1 | 1995 | 1 | 0.030 |
Why?
| Rana pipiens | 1 | 1995 | 2 | 0.030 |
Why?
| Mumps virus | 1 | 1995 | 19 | 0.030 |
Why?
| Interferon-beta | 1 | 1995 | 28 | 0.030 |
Why?
| Gene Library | 1 | 1995 | 50 | 0.030 |
Why?
| Xenopus laevis | 1 | 1995 | 49 | 0.030 |
Why?
| Motor Activity | 1 | 2017 | 247 | 0.030 |
Why?
| Genetic Vectors | 1 | 1995 | 139 | 0.030 |
Why?
| Stromal Cells | 1 | 2015 | 79 | 0.030 |
Why?
| Oncogene Protein v-akt | 1 | 2014 | 11 | 0.030 |
Why?
| Cell Polarity | 1 | 2014 | 19 | 0.030 |
Why?
| Mice, Knockout | 1 | 2017 | 926 | 0.030 |
Why?
| HIV-1 | 1 | 1994 | 72 | 0.030 |
Why?
| Sequence Analysis, DNA | 1 | 1995 | 273 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2021 | 1604 | 0.030 |
Why?
| Young Adult | 1 | 2024 | 4318 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 41 | 0.030 |
Why?
| Myelin Basic Protein | 2 | 2004 | 6 | 0.030 |
Why?
| Adipose Tissue | 1 | 2015 | 207 | 0.030 |
Why?
| MicroRNAs | 1 | 2017 | 386 | 0.030 |
Why?
| Enhancer Elements, Genetic | 1 | 1993 | 64 | 0.030 |
Why?
| Interleukin-12 Subunit p40 | 1 | 2012 | 2 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 673 | 0.030 |
Why?
| Lymphocyte Activation | 2 | 2004 | 197 | 0.030 |
Why?
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2011 | 2 | 0.030 |
Why?
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2011 | 4 | 0.030 |
Why?
| C-Reactive Protein | 1 | 2012 | 159 | 0.030 |
Why?
| Drug Inverse Agonism | 1 | 2011 | 18 | 0.030 |
Why?
| Retrospective Studies | 1 | 2023 | 6432 | 0.020 |
Why?
| HEK293 Cells | 1 | 2011 | 245 | 0.020 |
Why?
| Enzyme Induction | 1 | 1990 | 80 | 0.020 |
Why?
| Aged | 1 | 2024 | 10054 | 0.020 |
Why?
| Ferrous Compounds | 1 | 1989 | 11 | 0.020 |
Why?
| Aminolevulinic Acid | 1 | 1989 | 10 | 0.020 |
Why?
| RNA Probes | 1 | 1989 | 4 | 0.020 |
Why?
| Enzyme Stability | 1 | 1989 | 27 | 0.020 |
Why?
| Models, Molecular | 1 | 2011 | 423 | 0.020 |
Why?
| Interleukin-5 | 1 | 2009 | 6 | 0.020 |
Why?
| GATA3 Transcription Factor | 1 | 2009 | 4 | 0.020 |
Why?
| Half-Life | 1 | 1989 | 92 | 0.020 |
Why?
| T-Box Domain Proteins | 1 | 2009 | 14 | 0.020 |
Why?
| Interleukin-4 | 1 | 2009 | 48 | 0.020 |
Why?
| Microbial Viability | 1 | 2008 | 34 | 0.020 |
Why?
| Phagocytosis | 1 | 2008 | 51 | 0.020 |
Why?
| Fibronectins | 1 | 2008 | 41 | 0.020 |
Why?
| Proteoglycans | 1 | 2008 | 96 | 0.020 |
Why?
| Cell Wall | 1 | 2008 | 73 | 0.020 |
Why?
| Polyribosomes | 1 | 1987 | 8 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 1987 | 54 | 0.020 |
Why?
| Dicarbethoxydihydrocollidine | 1 | 1986 | 2 | 0.020 |
Why?
| Signal Transduction | 1 | 2014 | 1753 | 0.020 |
Why?
| Models, Immunological | 1 | 2006 | 10 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2007 | 92 | 0.020 |
Why?
| Psychiatric Status Rating Scales | 1 | 2007 | 346 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 923 | 0.020 |
Why?
| Anxiety | 1 | 2007 | 279 | 0.020 |
Why?
| Antigens, Surface | 1 | 2004 | 55 | 0.020 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2004 | 8 | 0.020 |
Why?
| Th2 Cells | 1 | 2004 | 26 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 2004 | 88 | 0.020 |
Why?
| T-Lymphocyte Subsets | 1 | 2004 | 41 | 0.020 |
Why?
| Growth Inhibitors | 1 | 2004 | 32 | 0.020 |
Why?
| Drug Combinations | 1 | 2004 | 128 | 0.010 |
Why?
| Immunization | 1 | 2004 | 95 | 0.010 |
Why?
| Cell Nucleus | 2 | 1994 | 203 | 0.010 |
Why?
| Case-Control Studies | 1 | 2007 | 1228 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 474 | 0.010 |
Why?
| Genes, T-Cell Receptor | 1 | 2002 | 5 | 0.010 |
Why?
| Adoptive Transfer | 1 | 2002 | 38 | 0.010 |
Why?
| Depression | 1 | 2007 | 595 | 0.010 |
Why?
| Lymph Nodes | 1 | 2004 | 284 | 0.010 |
Why?
| Carbon Radioisotopes | 1 | 2001 | 54 | 0.010 |
Why?
| Neoplasm Transplantation | 1 | 2001 | 94 | 0.010 |
Why?
| Transplantation, Heterologous | 1 | 2001 | 77 | 0.010 |
Why?
| Biotransformation | 1 | 2001 | 100 | 0.010 |
Why?
| Flow Cytometry | 1 | 2004 | 546 | 0.010 |
Why?
| Radionuclide Imaging | 1 | 2001 | 130 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 692 | 0.010 |
Why?
| Poly I-C | 1 | 1995 | 3 | 0.010 |
Why?
| HIV Long Terminal Repeat | 1 | 1994 | 4 | 0.010 |
Why?
| Oligonucleotide Probes | 1 | 1994 | 21 | 0.010 |
Why?
| NF-kappa B p50 Subunit | 1 | 1994 | 16 | 0.010 |
Why?
| Transcription Factor RelA | 1 | 1994 | 30 | 0.010 |
Why?
| Virus Latency | 1 | 1994 | 46 | 0.010 |
Why?
| Carcinoma, Embryonal | 1 | 1993 | 1 | 0.010 |
Why?
| Genome, Viral | 1 | 1994 | 100 | 0.010 |
Why?
| Embryonal Carcinoma Stem Cells | 1 | 1993 | 2 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1993 | 59 | 0.010 |
Why?
| DNA Primers | 1 | 1993 | 225 | 0.010 |
Why?
| Up-Regulation | 1 | 1995 | 508 | 0.010 |
Why?
| Binding Sites | 1 | 1994 | 440 | 0.010 |
Why?
| Neoplastic Stem Cells | 1 | 1993 | 103 | 0.010 |
Why?
|
|
Drew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|